Replies to post #1406 on Dare Bioscience Inc (DARE)

[Viewmont]

Daré Bioscience Inc. (DARE) CEO Sabrina Johnson on Q4 2018 Results - Earnings Call Transcript
Apr. 4, 2019 11:10 AM ET | About: Daré Bioscience, Inc. (DARE)
Q4: 04-01-19 Earnings Summary
Press Release

EPS of $-0.25 beats by $0.02

[Viewmont]

https://seekingalpha.com/pr/17460978-dare-bioscience-inc-host-business-update-full-year-2018-financial-results-conference-call

Q4: 04-01-19 Earnings Summary
Transcript

EPS of $-0.25 beats by $0.02

SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 8:30 a.m. Eastern Time on Thursday, April 4, 2019, to provide an update on portfolio strategic corporate initiatives and near-term clinical and regulatory milestones for 2019 and to review the Company's financial results for the year ended December 31, 2018.
To access the conference call via phone, dial [phone] (domestic) or [phone] (International). The conference ID number for the call is 2172598. The live webcast can be accessed under “Events & Presentations" in the Investor Relations section of the Company's website at www.darebioscience.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software. To access the replay, please call [phone] (U.S.) or [phone] (international). The conference ID number for the replay is 2172598. The telephone and webcast replay will be available until April 25, 2019.